ICZOOM Group Inc. Appoints Hantao Cui as Chief Strategy Officer and a Director

ICZOOM Group Inc. Appoints Hantao Cui as Chief Strategy Officer and a Director GlobeNewswire November 12, 2025 Hong Kong, Nov. 12, 2025 (GLOBE NEWSWIRE) — ICZOOM Group Inc. (Nasdaq: IZM) (the “Company”), a B2B electronic component products e-commerce platform, today announced the appointment of Ms. Hantao Cui as Chief Strategy Officer and a Director of […]

Skyline Builders Group Holding Limited Enters into Letter of Intent to Acquire SuperCritical Technologies

Skyline Builders Group Holding Limited Enters into Letter of Intent to Acquire SuperCritical Technologies GlobeNewswire November 12, 2025 â— Letter of Intent sets out terms for the acquisition of SuperCritical Technologies, a developer of technologies for the extraction of uranium and critical metals from seawater. â— American-developed technology to become a powerful driver of domestic

Asia Broadband Gold and Silver Production and Gross Profit Upward Trend Continues in the Third Quarter, As Gold and Silver Holdings Appreciated $38 Million Dollars

Asia Broadband Gold and Silver Production and Gross Profit Upward Trend Continues in the Third Quarter, As Gold and Silver Holdings Appreciated $38 Million Dollars GlobeNewswire November 12, 2025 LAS VEGAS, Nov. 12, 2025 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company will be

Axonius Strengthens Go-To-Market Leadership with Qualys and Okta Veterans to Drive Growth

Axonius Strengthens Go-To-Market Leadership with Qualys and Okta Veterans to Drive Growth Appointment of Klaus Moser as SVP of Global Sales and Ernesto Tey as VP of Global Partners and Alliances adds proven public-company leadership to accelerate the company's next phase of growth GlobeNewswire November 12, 2025 NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) —

TRUE-See Presentations at IPAWS Summit Highlight Potential of Its Technology to Increase the Accuracy and Utility of Medical Photographic Imaging in Wound Care

TRUE-See Presentations at IPAWS Summit Highlight Potential of Its Technology to Increase the Accuracy and Utility of Medical Photographic Imaging in Wound Care New Data Shows TRUE-See's Color Calibrated Technology Significantly Increases the Accuracy of Routine Medical Photographs and Enables Development of AI-Assisted Medical Photographic Imaging for Wound Care and Other Applications GlobeNewswire November 12,

Gaxos to Participate in Upcoming WAWTech Conference on December 16th and 17th in Warsaw, Poland

Gaxos to Participate in Upcoming WAWTech Conference on December 16th and 17th in Warsaw, Poland GlobeNewswire November 12, 2025 Roseland, NJ, Nov. 12, 2025 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various high-growth sectors, today announced its participation in the upcoming WAWTech Conference, taking place on

Astiva Health Receives 2026 Senior Choice Gold Award, Reinforcing Market Leadership in Medicare Advantage

Astiva Health Receives 2026 Senior Choice Gold Award, Reinforcing Market Leadership in Medicare Advantage National recognition from HealthMetrix Research highlights Astiva's differentiated value, quality performance, and strategic focus on culturally aligned care across California GlobeNewswire November 12, 2025 ORANGE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — via IBN — Astiva Health (or the “Company”), a

Aviatrix(R) Launches Zero Trust for Workloads: Pervasive Cross-Cloud Enforcement for AI and Cloud Native Environments

Aviatrix(R) Launches Zero Trust for Workloads: Pervasive Cross-Cloud Enforcement for AI and Cloud Native Environments New Product Line Delivers Inline Zero Trust Enforcement and Continuous Visibility Across VMs, Containers, Kubernetes, and Serverless Workloads GlobeNewswire November 12, 2025 Santa Clara, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Aviatrix(R) today introduced Zero Trust for Workloads, a new

NeOnc Technologies Reports Updated Clinical Results

NeOnc Technologies Reports Updated Clinical Results Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 GlobeNewswire November 12, 2025 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage

Scroll to Top